Educational content on VJNeurology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.
Bárbara Guerra Leal, PhD, University of Porto, Porto, Portugal, discusses the potential use of inflammatory microRNAs as biomarkers for predetermining the onset of MS. An initial trial provided positive results, but further testing is required in order to establish its efficacy. This interview took place during the European Academy of Neurology 2021 congress.
We use necessary cookies to make this site work. Analytics, preference, and marketing cookies are used only if you choose to allow them. You can change your choice at any time. For more information view our Cookie Policy.